HC Wainwright & Co. Reiterates Buy on Dynavax Technologies, Maintains $29 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Edward White has reiterated a Buy rating on Dynavax Technologies (NASDAQ:DVAX) and maintained a $29 price target.
May 14, 2024 | 3:19 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating and a $29 price target for Dynavax Technologies, indicating a positive outlook on the stock.
The reiteration of a Buy rating and maintenance of a $29 price target by a reputable analyst firm like HC Wainwright & Co. can have a positive impact on investor sentiment towards Dynavax Technologies. This endorsement may lead to increased investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100